Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results
MALVERN, Pa., Jan. 12, 2021 Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today, in advance of the ICR/Westwicke Conference, announced certain preliminary unaudited fourth quarter and full year 2020 revenue results.
Fourth Quarter 2020
Fourth quarter 2020 preliminary unaudited revenue between $15.0 and $15.5 million compared to previously issued guidance of $13.0 and $13.5 million. This represents a sequential increase of between 21% and 25% compared to third quarter 2020.